Home
Evan Lippman, EVP, Business Development: Teva Pharmaceutical Industries TEVA Sell · Filed 05/18
Trade details
- Type
- Insider sale
- Amount
- $1,277,748.96
- Shares · price
- 35,912 sh · $35.58 a share
- Held after
- 44,191 sh
- Trade date
- 26/05/14
- Filed
- 26/05/18
- Days to filing
- 4 days
Sold 44.8% of holdings
- Share of holding sold
- 44.8%
Teva Pharmaceutical Industries trades, last 26 weeks
What else happened in Teva Pharmaceutical Industries around then
Filed or reported within 30 days of the trade day · 04/14~06/13Evan Lippman's recent trades
- Evan Lippman
Planned sale10b5-1 planTeva Pharmaceutical Industries
Planned sale10b5-1 planTeva Pharmaceutical Industries
TEVA
$680.3K
18,600 sh
$680.3K
Filed 08/17
Traded 08/17
- Evan Lippman
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 planTeva Pharmaceutical Industries
TEVA
$204.4K
5,746 sh
$204.4K
Filed 05/18
Traded 05/14
- Evan Lippman
Planned sale10b5-1 planTeva Pharmaceutical Industries
Planned sale10b5-1 planTeva Pharmaceutical Industries
TEVA
$1.5M
41,658 sh
$1.5M
Filed 05/14
Traded 05/14